154 related articles for article (PubMed ID: 21099364)
1. Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies.
Mihalcik SA; Tschumper RC; Jelinek DF
Cell Cycle; 2010 Dec; 9(24):4884-92. PubMed ID: 21099364
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.
Onda K; Iijima K; Katagiri YU; Okita H; Saito M; Shimizu T; Kiyokawa N
Int J Hematol; 2010 Jun; 91(5):808-19. PubMed ID: 20428981
[TBL] [Abstract][Full Text] [Related]
3. The structure of the TNFRSF13C promoter enables differential expression of BAFF-R during B cell ontogeny and terminal differentiation.
Mihalcik SA; Huddleston PM; Wu X; Jelinek DF
J Immunol; 2010 Jul; 185(2):1045-54. PubMed ID: 20554963
[TBL] [Abstract][Full Text] [Related]
4. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells.
Nimmanapalli R; Lyu MA; Du M; Keating MJ; Rosenblum MG; Gandhi V
Blood; 2007 Mar; 109(6):2557-64. PubMed ID: 17119117
[TBL] [Abstract][Full Text] [Related]
5. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.
Parameswaran R; Müschen M; Kim YM; Groffen J; Heisterkamp N
Cancer Res; 2010 Jun; 70(11):4346-56. PubMed ID: 20460528
[TBL] [Abstract][Full Text] [Related]
6. Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia.
Jasek M; Bojarska-Junak A; Wagner M; Sobczyński M; Wołowiec D; Roliński J; Karabon L; Kuśnierczyk P
Tumour Biol; 2016 Oct; 37(10):13617-13626. PubMed ID: 27468724
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene.
Yuan H; Wang Y; Wu X; Wang H; Pu J; Ding W; Wang M; Shen X; Cong H; Zhang L; Zhang M; Ju S
DNA Cell Biol; 2010 Mar; 29(3):133-9. PubMed ID: 20025535
[TBL] [Abstract][Full Text] [Related]
8. Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.
Cols M; Barra CM; He B; Puga I; Xu W; Chiu A; Tam W; Knowles DM; Dillon SR; Leonard JP; Furman RR; Chen K; Cerutti A
J Immunol; 2012 Jun; 188(12):6071-83. PubMed ID: 22593611
[TBL] [Abstract][Full Text] [Related]
9. APRIL is overexpressed in cancer: link with tumor progression.
Moreaux J; Veyrune JL; De Vos J; Klein B
BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins.
Kohno T; Daa T; Otani H; Shimokawa I; Yokoyama S; Matsuyama T
Genes Cells; 2008 Oct; 13(10):1061-73. PubMed ID: 18775026
[TBL] [Abstract][Full Text] [Related]
12. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells.
Shen X; Zhu W; Zhang X; Xu G; Ju S
Mol Cell Biochem; 2011 Nov; 357(1-2):21-30. PubMed ID: 21607696
[TBL] [Abstract][Full Text] [Related]
13. B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia.
Zhang W; Kater AP; Widhopf GF; Chuang HY; Enzler T; James DF; Poustovoitov M; Tseng PH; Janz S; Hoh C; Herschman H; Karin M; Kipps TJ
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18956-60. PubMed ID: 20956327
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
[TBL] [Abstract][Full Text] [Related]
15. BAFF controls neural cell survival through BAFF receptor.
Tada S; Yasui T; Nakatsuji Y; Okuno T; Koda T; Mochizuki H; Sakoda S; Kikutani H
PLoS One; 2013; 8(7):e70924. PubMed ID: 23923031
[TBL] [Abstract][Full Text] [Related]
16. An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemia.
Ullah MA; Garcillán B; Whitlock E; Figgett WA; Infantino S; Eslami M; Yang S; Rahman MA; Sheng YH; Weber N; Schneider P; Tam CS; Mackay F
Front Immunol; 2024; 15():1345515. PubMed ID: 38469292
[TBL] [Abstract][Full Text] [Related]
17. The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
Wu DH; Xu L; Wen CP; Xie GQ; Ji JJ; Pan JL; Jiao YF; Fan YS
PLoS One; 2015; 10(2):e0118462. PubMed ID: 25689512
[TBL] [Abstract][Full Text] [Related]
18. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.
Bojarska-Junak A; Hus I; Chocholska S; Wasik-Szczepanek E; Sieklucka M; Dmoszyńska A; Roliński J
Leuk Res; 2009 Oct; 33(10):1319-27. PubMed ID: 19395025
[TBL] [Abstract][Full Text] [Related]
19. TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia.
Fazio G; Turazzi N; Cazzaniga V; Kreuzaler M; Maglia O; Magnani CF; Biagi E; Rolink A; Biondi A; Cazzaniga G
Br J Haematol; 2018 Aug; 182(3):434-436. PubMed ID: 28573703
[No Abstract] [Full Text] [Related]
20. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
